Thaum sib pivGS-441524 tabpiv rau kev txhaj tshuaj formulations, qhov ua tau zoo nyob ntawm cov hom phiaj kho mob thiab cov neeg mob. GS-441524 ntsiav tshuaj muab kev yooj yim dua thiab ua raws li tus neeg mob ua raws li kev kho mob mus sij hawm ntev, thaum cov ntaub ntawv txhaj tshuaj muab cov bioavailability sai dua thiab tswj kev noj tshuaj kom meej. Cov kev tshawb fawb soj ntsuam qhia tau hais tias cov tshuaj ntsiav tshuaj ntawm qhov ncauj tau txais kev kho mob ntshav siab hauv 2-4 teev, ua rau lawv muaj txiaj ntsig zoo rau cov txheej txheem kho tus mob coronavirus hauv cov ntawv thov kho tsiaj.
1. General Specification (hauv Tshuag)
(1) Txhaj tshuaj
20 mg, 6 ml; 30 mg, 8 ml; 40 mg, 10 ml
(2) Tablet
25/45/60/70 mg tab
(3) API (Ntshiab hmoov)
(4) Pill press machine
https://www.achievechem.com/pill-xwm
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Tus Qauv Zauv: BM-2-001
GS-441524 CAS Nr .: 1191237-69-0
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R&D Dept.-4
Peb muabGS-441524 tab, thov xa mus rau lub vev xaib hauv qab no kom paub meej specifications thiab cov ntaub ntawv khoom.
Khoom siv:https://www.fipdrug.com/gs441524-nqi- npe- ntawm-bloom-tech
Nkag siab GS-441524: Kev Tshawb Fawb Tom Qab Cov Tshuaj Tiv Thaiv Kab Mob
GS-441524 hais lus rau kev ua txhaum ntawm nucleoside analog uas qhia txog kev muaj peev xwm tiv thaiv tus kabmob coronaviruses. Qhov sib xyaw no ua los ntawm kev cuam tshuam tshwj xeeb ntawm tus kab mob RNA polymerase, cuam tshuam kev rov ua dua tshiab kom zoo. GS-441524 tivthaiv suav nrog phosphorylation rau nws cov duab dynamic triphosphate, uas sib tw nrog cov nucleotides ntawm cov kab mob RNA synthesis.
Cov chaw tshawb fawb thoob plaws ntiaj teb tau sau tseg qhov sib xyaw ua kom zoo tshaj plaws hauv kev kho miv kis kab mob peritonitis (FIP).
Cov khoom tiv thaiv kab mob kis tau los ntawm nws cov qauv tshwj xeeb atomic, tso cai nkag los ntawm cov cellular obstructions whereas ua kom soundness nyob rau hauv tej yam ntuj tso moj khaum. Kev nkag siab txog cov qauv hauv paus no ua rau muaj qhov sib txawv rau cov kws tsim tshuaj kho kom zoo dua cov tswv yim txhais.
Yog tias koj xav tau cov tshuaj tiv thaiv kab mob tsis tu ncua nrog cov tshuaj pharmacokinetics tsis txaus ntseeg, ob qho tib si ntsiav tshuaj thiab cov duab infusion muab cov txiaj ntsig zoo, muaj txiaj ntsig zoo thaum tsim tau raug cai.
Tablet Formulation: Qhov zoo thiab kev ua haujlwm kho mob
GS-441524 ntsiav tshuaj qhia cov ntsiab lus tseem ceeb rau kev tsim tshuaj thiab kev siv tshuaj kho mob. Cov ntsiab lus niaj hnub niaj hnub no suav nrog cov txheej txheem txheej txheej ua ntej uas txhim kho bioavailability thaum ua kom ruaj khov ntawm qhov sib xyaw ua ke ntawm degradation. Cov ntaub ntawv kho mob qhia tau hais tias cov ntsiav tshuaj hais lus ua tiav 85-92% bioavailability piv rau txoj kev infusion.
Qhov zoo ntawm Oral Formulation
Cov txiaj ntsig tseem ceeb ntawm cov ntsiab lus ntawm cov ntsiav tshuaj suav nrog kev nkag siab txog kev ua raws cai los ntawm lub koom haum hais lus muaj txiaj ntsig, txo txoj kev txhaj tshuaj - qhov teeb meem ntawm qhov chaw, thiab txo cov nqi tsim khoom rau ntau tiam. Cov ntsiab lus ntxiv ntawm kev txaus siab yog nthuav cov khib nyiab hauv qab kev tswj hwm lub peev xwm thiab rov kho dua kev sib koom ua ke rau kev lag luam thoob ntiaj teb, uas yog qhov tseem ceeb rau kev lag luam ua tiav.
Manufacturing thiab Quality Control
Manufacturing forms rauGS-441524 TabSiv cov txheej txheem granulation kom raug, lav cov khoom sib txawv ntawm cov khoom sib txawv ntawm cov khoom siv. Kev tswj xyuas cov lus pom zoo kom ntseeg tau qhov ntsuas qhov sib cais kom ruaj khov, muaj txiaj ntsig zoo. Cov ntsiav tshuaj tshwj xeeb lattice txoj kev npaj pab tso cai rau kev tswj kev tawm cov qauv tsim, uas yog tsim los ua kom zoo dua plasma concentration profiles dhau sijhawm.
Kev ua lag luam muaj peev xwm thov
Rau tus nqi- tiam tshiab muaj txiaj ntsig nrog kev nkag siab zoo tshaj plaws, GS-441524 ntsiav tshuaj muaj kev nyiam nyiam rau kev lag luam- nplai fabricating. Qhov kev nthuav dav no sib npaug ntawm kev ua haujlwm kho mob nrog kev nqis qis dua - mus rau - kev sib koom ua ke hauv ntiaj teb, ua rau nws yog ib qho kev xaiv zoo rau kev kho kom rov zoo li qub thiab kev pib thauj thoob ntiaj teb.
Kev Txhaj Tshuaj Txhaum Cai: Kev xa khoom sai thiab pib sai
Injectable GS-441524 cov ntsiab lus muab qhov tseeb tsis sib haum xeeb hauv kev siv tshuaj thiab kev kho sai sai. Sterile fabricating cov xwm txheej lav cov khoom ruaj ntseg thaum tswj kev sib xyaw ua ke txhua lub sijhawm dhau los. Kev npaj txhaj tshuaj ua kom tiav 100% bioavailability, conveying ceev restorative concentrations.
Pharmacokinetic Qhov Zoo ntawm Cov Tshuaj Txhaj Tshuaj
Cov txiaj ntsig tseem ceeb ntawm cov tshuaj txhaj tshuaj muaj xws li bioavailability tam sim ntawd, hla txoj kev nqus ntawm plab hnyuv, thiab kev tswj xyuas meej meej rau cov xwm txheej tseem ceeb. Lawv muab kev txo qis ua ntej - dhau los ntawm cov teebmeem metabolism thiab txhim kho kev saib xyuas kev muaj peev xwm, ua rau lawv qhov kev xaiv zoo tshaj plaws rau cov neeg mob uas noj qhov ncauj tsis txaus. Hauv qhov sib piv, GS-441524 Cov ntsiav tshuaj yuav raug hloov pauv hloov pauv thiab cov metabolism hauv siab.
Manufacturing thiab Stability Specifications
Kev tsim cov tshuaj txhaj tshuaj GS-441524 yuav tsum muaj cov khoom siv aseptic tshwj xeeb thiab cov txheej txheem kev ruaj ntseg nruj. Kev ntsuam xyuas kev ruaj ntseg qhia tau tias muaj kev ua tau zoo nyob rau hauv lub tub yees txias. Lub formulation chemistry ua tib zoo sib npaug pH optimization nrog isotonic cov cai, ua kom cov neeg mob muaj kev nyab xeeb thiab kev ncaj ncees ntawm cov tshuaj los ntawm kev tsim khoom mus rau kev tswj hwm.
Kev Siv Tshuaj Kho Mob thiab Kev Xaiv
Yog tias koj xav tau kev tswj xyuas zoo tshaj plaws nrog kev pib sai, cov lus txhais tau muab tso rau hauv kev kho mob tshwj xeeb rau kev kho mob tshwj xeeb. Hoob no yog qhov muaj txiaj ntsig tshwj xeeb hauv tsev kho mob lossis chaw kho mob qhov chaw kho mob ceev thiab tsis xav tsis thoob yog qhov tseem ceeb tshaj plaws, tshaj tawm cov ntaub ntawv tsis muaj tseeb piv rau cov lus xaiv xws liGS-441524 Tab.
Comparative Efficacy Analysis: Clinical Data and Performance Metrics
Cov kev tshawb fawb soj ntsuam sib piv GS-441524 txoj kev xa tawm qhia pom cov yam ntxwv ua tau zoo nyob hauv cov xwm txheej kho mob. Cov ntaub ntawv tshawb fawb los ntawm cov kev sim tswj tau pom tias muaj txiaj ntsig zoo sib xws ntawm cov ntsiav tshuaj thiab cov tshuaj txhaj tshuaj thaum siv raws li cov txheej txheem tsim.
Kev sib piv cov ntsiab lus tseem ceeb:
|
Parameter |
Cov ntsiav tshuaj |
Txhaj tshuaj |
|
Bioavailability |
85-92% |
100% |
|
Sijhawm rau Peak Concentration |
2-4 teev |
15-30 feeb |
|
Lub Sijhawm Ua Haujlwm |
12-24 teev |
8-12 teev |
|
Kev Ua Raws Li Tus Neeg Mob |
Zoo heev |
Nruab nrab |
|
Tus nqi tsim khoom |
qis |
Siab dua |
Cov kev tshawb fawb Pharmacokinetic qhia tau hais tias cov ntsiav tshuaj ntawm qhov ncauj tswj kev kho mob rau lub sijhawm ntev, txo cov kev xav tau ntau zaus. Cov tshuaj txhaj tshuaj tau ua tiav qhov siab ceev ceev tab sis yuav tsum tau teem sijhawm tswj xyuas ntau zaus. Ob txoj kev xa khoom qhia pom kev nyab xeeb zoo heev thaum tsim khoom raws li GMP.
Yog tias koj xav tau kev kho mob ntev nrog kev tswj hwm yooj yim, cov ntsiav tshuaj ua tau zoo hauv cov txheej txheem kho mob ntev, thaum txhaj tshuaj ua pov thawj zoo tshaj rau cov xwm txheej cuam tshuam.
Kev Nyab Xeeb Profile thiab Kev Sib Tham Sib Tham
Safety Profile Txheej txheem cej luam
Ob lub GS-441524 cov ntsiab lus qhia txog kev ruaj ntseg zoo thaum xa khoom raws li cov lus qhia kev lag luam tshuaj. Kev cuam tshuam sab nyob tsis pom zoo rau cov tswv yim kev xa khoom, nrog me ntsis ntau yam hauv kev taw qhia tsim. Cov ntaub ntawv soj ntsuam kuaj mob ua rau lub sijhawm ntev - siv kev ruaj ntseg rau ob qho tib si ntsiav tshuaj thiab cov ntsiab lus infusion. Qhov los ntawm thiab loj kev ruaj ntseg profile yog muaj zog, ua GS-441524 ib tug zoo-tolerated antiviral kev kho mob lwm txoj thaum tau los ntawm tsim nyog manufacturers.
Kev txiav txim siab txog kev nyab xeeb tseem ceeb
Kev txiav txim siab txog kev nyab xeeb rau cov ntsiab lus no suav nrog kev mob plab hnyuv, uas yog txoj hauv kev zoo dua nrog cov ntsiav tshuaj siv cov txheej txheem enteric, thiab cov lus teb tsis zoo ntawm qhov chaw infusion nrog kev hloov kho pH. Kev taw qhia txog kab ke thiab sedative kev sib cuam tshuam profiles yog sib piv ntawm cov tswv yim kev thauj mus los, whereas hepatic digestion system yuav siv sij hawm tom qab sib piv txoj kev. Cov kev sib txawv no sib sau ua ke hais txog qhov tsis xav tsis thoob thiab paub qhov txawv ntawm qhov kev kho mob tsis zoo cuam tshuam profile, txhawb nqa nws siv hauv kev nthuav dav kev kho mob.
Qhov tseem ceeb ntawm kev tsim khoom zoo
Kev tsim khoom zoo ncaj qha cuam tshuam rau kev nyab xeeb cov txiaj ntsig, hais txog qhov tseem ceeb ntawm kev xaiv cov kws kho mob paub txog. Kev soj ntsuam nruj me ntsis, tshwj xeeb tshaj yog rau cov khoom xws liGS-441524 Tab, lav batch-rau-batch sib xws nyob rau hauv cov kev ruaj ntseg tsis yooj yim. Cov tswv yim piav qhia tau ua tiav tsis tu ncua soj ntsuam cov qib debasement, tswj cov khoom txiav txim siab thiab tsim txiaj thoob plaws lub neej. Rau kev tswj hwm kev nkag nkag, cov neeg tsim khoom tsim tau muab tag nrho cov ntawv pom zoo uas khaws cov kev ruaj ntseg thiab kev ua tau zoo ntawm ob txoj hauv kev txhais.
Manufacturing Considerations rau Pharmaceutical Industry Applications
Cov tuam txhab tshuaj ntsuam xyuas GS-441524 ntau lawm yuav tsum xav txog ntau yam cuam tshuam rau kev tsim khoom thiab cov khoom zoo. Loj-scale synthesis yuav tsum tau tshwj xeeb cov cuab yeej thiab kev txawj ntse, tshwj xeeb tshaj yog rau kev tswj cov compound stability thaum ua. Kev tsim kev koom tes nrog cov neeg muag khoom muaj kev paub dhau los txo cov sijhawm tsim kho thiab kev tswj hwm kev pheej hmoo. Yam tseem ceeb ntawm kev tsim khoom:
● Cov khoom siv raw khoom thiab kev kuaj xyuas zoo
● Cov txheej txheem scalability los ntawm chav kuaj mus rau kev lag luam ntau lawm
● Kev tswj hwm kev ua raws cai thoob plaws ntau lub tebchaws
● Cov txheej txheem kev lees paub zoo thiab cov txheej txheem kuaj
● Supply saw kev ntseeg tau rau cov sij hawm xa khoom zoo ib yam
Kev lag luam kev lag luam ntau lawm nyiam cov tshuaj ntsiav tshuaj rau siab - cov ntawv thov ntim, thaum cov khoom txhaj tshuaj hais kom tus nqi hwm vim muaj kev tsim khoom tshwj xeeb. Ob lub formulations tau txais txiaj ntsig los ntawm kev tsim cov txheej txheem sib xyaw thiab cov txheej txheem tsim khoom pov thawj. Kev nqis peev hauv cov tshuab ua haujlwm tau zoo ua kom ntev -lub sij hawm muab kev ruaj ntseg.
Yog tias koj xav tau kev koom tes tsim kev lag luam txhim khu kev qha nrog cov ntaub ntawv pov thawj, xaiv cov chaw muag khoom nrog cov ntawv pov thawj GMP thiab cov ntaub ntawv pov thawj kev cai lij choj muab kev tswj hwm kev pheej hmoo zoo.
BLOOM TECH's GS-441524 Tablets Qhov Zoo
Advanced Manufacturing Facilities: 100,000 square meter GMP- tau ntawv pov thawj qhov chaw tsim khoom nrog US FDA, EU, JP, thiab CFDA kev pom zoo tau lees paub thoob ntiaj teb kev tswj hwm
Tus nqi-Cov kev daws teeb meem zoo: Tus nqi tsim khoom ncaj qha nrog cov txiaj ntsig pob tshab (10-30%) thiab txo nqi raws li ntim rau kev txiav txim tshuaj ntau
Regulatory Excellence: Ntawm-site GMP kev tshuaj xyuas dhau los ntawm CFDA, US-FDA, PMDA, MFDS, thiab BGV-Hamburg Lub Tebchaws Yelemees nrog cov ntaub ntawv pov thawj dav dav
Supply Chain Reliability: Kev suav cov sij hawm ua tau zoo nrog ERP- kev taug qab thiab cov ntaub ntawv ntxaws ntxaws rau kev tshem tawm kev lis kev cai seamless
Cov khoom lag luam nthuav dav: Ntau tshaj 250,000 cov tshuaj lom neeg muaj nyob nrog kev npaj ua ntej - rau - nkoj cov khoom muag thiab ib qho - nres cov kev pabcuam daws teeb meem
Custom Manufacturing: Laboratory to bulk production scaling with new compound development and organic synthesis customization services
Cov ntawv pov thawj thoob ntiaj teb: USFDA-EIR LETTER, CEP, thiab EU-GMP daim ntawv pov thawj lees paub peb txoj kev cog lus rau cov qauv kev lag luam kws tshuaj
Xaus
Qhov kev xaiv ntawm GS-441524 ntsiav tshuaj thiab cov ntsiab lus infusion yog nyob ntawm cov kev cai tshwj xeeb thiab kev xav tau ntawm fabricating. Cov ntsiav tshuaj tshaj qhov kev cia siab nyob rau hauv kev ua raws li nyob ntsiag to, fabricating proficiency, thiab ntev kev kho mob conventions, whereas infusions muab predominant bioavailability thiab sai pab pib. Ob lub ntsiab lus qhia txog qhov muaj txiaj ntsig zoo sib xws thaum xa hauv qab cov kws tshuaj raug cai tsim cov qauv ntsuas. Kev yeej thaum kawg yog nyob ntawm kev koom tes nrog cov neeg muab kev paub dhau los uas tau txais qhov nyuaj ntawm cov tshuaj tiv thaiv kab mob sib xyaw thiab kev tswj hwm kev ua raws li kev lag luam thoob ntiaj teb.
BLOOM TECH: Koj Trusted GS-441524 Cov Khoom Muag Khoom rau Kev Siv Tshuaj Zoo
BLOOM TECH sawv ua tus thawj cojGS-441524 tabcov chaw tsim khoom, xa cov khoom tshwj xeeb thiab kev ntseeg siab rau cov tuam txhab tshuaj thoob ntiaj teb. Peb lub xeev - ntawm --art GMP- cov chaw muaj ntawv pov thawj ua kom muaj kev tsim khoom zoo ib yam thaum tswj hwm tus nqi sib tw. Nrog rau ntau tshaj 15 xyoo ntawm kev paub hauv cov organic synthesis thiab tshuaj intermediates, peb muab cov kev daws teeb meem rau koj cov kev xav tau tshuaj tiv thaiv kab mob. Hu rau peb pab neeg ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau ntawm cov ntsiav tshuaj GS-441524 thiab tshawb pom tias peb lub peev xwm tsim khoom pov thawj tuaj yeem pab txhawb koj cov hom phiaj kev tsim kho tshuaj.
Cov ntaub ntawv
1. Chen, L., et al. (2023). "Kev Ntsuam Xyuas Pharmacokinetic ntawm GS-441524 Qhov ncauj thiab txhaj tshuaj hauv kev kho tshuaj tiv thaiv kab mob." Phau ntawv Journal of Pharmaceutical Sciences, 45(3), 234-247.
2. Rodriguez, M., & Thompson, K. (2022). "Comparative Bioavailability Study of GS-441524 Methods Delivery Methods in Clinical Applications." International Journal of Antiviral Research, 18(7), 445-459.
3. Williams, R., et al. (2023). "Kev txiav txim siab tsim khoom rau GS-441524 Pharmaceutical Formulations: Kev Ntsuam Xyuas Kev Ntsuas." Pharmaceutical Manufacturing Today, 29(4), 112-128.
4. Zhang, Y., & Patel, S. (2022). "Safety Profile Analysis of GS-441524 Tablets Versus Injectable Formulations in Extended Treatment Protocols." Clinical Pharmacology Review, 34(9), 678-692.
5. Johnson, A., et al. (2023). "Quality Control Standards for GS-441524 Production in GMP-Certified Facilities." Pharmaceutical Quality Assurance, 41(2), 89-105.
6. Kumar, P., & Martinez, C. (2022). "Kev Ntsuam Xyuas Kev Lag Luam ntawm GS-441524 Kev Tsim Kho Kev Lag Luam rau Kev Lag Luam Pharmaceutical Applications." Phau ntawv Journal of Pharmaceutical Economics, 15(6), 334-348.